Latest Shareholder Approval News

MAC Copper has secured Foreign Investment Review Board approval, satisfying all regulatory conditions for its acquisition by Harmony Gold’s Australian subsidiary. The deal now awaits shareholder votes and court sanction to proceed.

betr Entertainment has withdrawn its Notice of Meeting and cancelled the Selective Buy-Back Meeting following an undertaking with the Takeovers Panel related to its takeover offer for PointsBet. A new combined shareholder meeting will be called soon.

Lake Resources has tapped its At-the-Market facility to raise A$1.575 million, aiming to fund key development stages of its flagship Kachi lithium project in Argentina.

Lake Resources has successfully raised up to A$12 million through a strongly supported placement, bolstering its financial position to advance the Kachi lithium project in Argentina.

Silk Logistics Holdings has completed its acquisition by DP World Australia, with shareholders paid A$2.14 per share and the company set for imminent ASX delisting.

Rhythm Biosciences has launched a $3.75 million placement alongside an offer of over 52 million new options, all contingent on shareholder approval. The move aims to bolster working capital as the company advances its cancer diagnostic products.

Mount Burgess Mining has acquired two promising gold projects in Western Australia, Viking and Blair North, with plans to commence drilling in late 2025. The acquisitions come with strong historical drill results and a $900,000 capital raise to fund exploration.

Mount Burgess Mining has inked binding agreements to acquire two promising high-grade gold projects in Western Australia, setting the stage for exploration drilling in late 2025 backed by a $900,000 capital raise.

Rhythm Biosciences has announced a $3.75 million placement to accelerate the commercial launch of its ColoSTAT® cancer detection test and expand its geneType™ product suite into key markets. The capital raise includes director participation and attaching options, pending shareholder approval.

Rhythm Biosciences is raising up to $3.75 million through a share placement to fund the launch of its ColoSTAT® colorectal cancer diagnostic and accelerate commercialization of its geneType™ portfolio.

Apiam Animal Health has received a non-binding indicative proposal from Adamantem Capital Management to acquire the company at $0.88 per share, sparking a potential shift in ownership for the veterinary services leader.

betr Entertainment Limited has launched a superior all-scrip takeover offer for PointsBet Holdings Limited, valuing PointsBet shares between $1.22 and $1.29 each and aiming to create Australia’s fourth largest online wagering operator. The deal promises substantial cost synergies and strategic growth opportunities.